Clinical Report: Biopsy versus Ablation in Butterfly Gliomas
Overview
This study compares outcomes of biopsy and laser interstitial thermal therapy (LITT) in patients with butterfly gliomas, focusing on survival metrics, post-operative complications, and neurological function associated with each treatment modality.
Background
Butterfly gliomas are a rare and aggressive form of glioblastoma, often leading to poor prognosis and limited treatment options. Traditional approaches have focused on biopsy and chemoradiation. Recent studies have explored surgical resection as a treatment option, but the evidence is not conclusive.
Data Highlights
No numerical data provided in the source material.
Key Findings
Butterfly gliomas account for 3–14% of all glioblastomas and have a median survival of 3.2 to 6.3 months.
These tumors have historically been treated primarily with biopsy due to surgical inaccessibility.
Some studies suggest surgical resection may provide survival benefits over biopsy alone, but evidence is limited.
LITT has shown safety and feasibility in treating butterfly gliomas, although comparative data is limited.
The study aims to compare outcomes of biopsy versus LITT in terms of survival and complications.
Clinical Implications
Clinicians should consider the risks of neurological morbidity associated with traditional surgical approaches.
Conclusion
This study highlights the need for further investigation into treatment modalities for butterfly gliomas.
by Vratko Himic, Morgan Leigh Johnson, Anshul Ratnaparkhi, Roxanne C. Mayrand, Jay Chandar, Vaidya Govindarajan, Daniel C. Kreatsoulas, Arman Jahangiri, Zachary C. Gersey, Daniel M. Aaronson, Ricardo J. Komotar, Micheal E. Ivan, Ashish H. Shah
